Geron (GERN) Net Cash Flow (2010 - 2026)
Geron's (GERN) quarterly Net Cash Flow came in at -$6.1 million in Q2 2026, down 2.31% year-over-year from -$6.3 million in Q2 2025, and up 28.72% quarter-over-quarter from -$8.6 million in Q1 2026.
Analysis
Geron (GERN) Net Cash Flow (2010 - 2026) Analysis & Trends
Geron has disclosed Net Cash Flow across 17 years of filings, most recently posting -$6.1 million for Q2 2026.
- In Q2 2026, Net Cash Flow fell 2.31% year-over-year to -$6.1 million; the TTM figure through Jun 2026 stood at -$15.0 million (up 61.04% YoY), while the FY2025 annual figure was -$1.5 million, down 115.62% from the prior year.
- Net Cash Flow came in at -$6.1 million for Q2 2026 at Geron, up from -$8.6 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $119.8 million in Q1 2024 to a low of -$72.8 million in Q2 2024.
- Average Net Cash Flow over 5 years is -$2.3 million, with a median of -$5.1 million recorded in 2022.
- Year-over-year, Net Cash Flow soared 1677.36% in 2023 and slumped 282.89% in 2026.
- Over 5 years, Net Cash Flow stood at -$4.3 million in 2022, then surged by 1034.68% to $39.9 million in 2023, then sank by 53.13% to $18.7 million in 2024, then plunged by 102.91% to -$544000.0 in 2025, then sank by 1030.15% to -$6.1 million in 2026.
- Per Business Quant data, the three most recent Net Cash Flow figures were -$6.1 million in Q2 2026, -$8.6 million in Q1 2026, and -$544000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 1.95 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -4.43 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 652.90 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | -504.30 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -183.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | -496,000.00 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -2.09 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -170.75 Mn |
| 10 | Geron | 914.60 Mn | 613.75 Mn | - | -6.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.15 Mn |
| Mar 31, 2026 | -8.63 Mn |
| Dec 31, 2025 | -544,000.00 |
| Sep 30, 2025 | 314,000.00 |
| Jun 30, 2025 | -6.01 Mn |
| Mar 31, 2025 | 4.72 Mn |
| Dec 31, 2024 | 18.71 Mn |
| Sep 30, 2024 | -55.92 Mn |
| Jun 30, 2024 | -72.79 Mn |
| Mar 31, 2024 | 119.75 Mn |
| Dec 31, 2023 | 39.91 Mn |
| Sep 30, 2023 | -26.20 Mn |
| Jun 30, 2023 | -55.71 Mn |
| Mar 31, 2023 | 55.95 Mn |
| Dec 31, 2022 | -4.27 Mn |
| Sep 30, 2022 | -14.96 Mn |
| Jun 30, 2022 | -25.83 Mn |
| Mar 31, 2022 | -3.55 Mn |
| Dec 31, 2021 | 5.84 Mn |
| Sep 30, 2021 | -28.25 Mn |